EX-99.1 2 dex991.htm INVESTOR RELATIONS SLIDE SHOW Investor Relations Slide Show
Welcome 
2011 Investor Meeting -
NYC  
April 2011
Exhibit 99.1

2011 Investor Meeting
Forward-looking statements
www.amedisys.com
NASDAQ: AMED
We encourage everyone to visit the
Investors Section of our website at
www.amedisys.com, where we have
posted additional important
information such as press releases,
profiles concerning our business and
clinical operations and control
processes, and SEC filings.
We intend to use our website to
expedite public access to time-critical
information regarding the Company in
advance of or in lieu of distributing a
press release or a filing with the SEC
disclosing the same information.
2
This presentation may include forward-looking statements as defined by the Private
Securities Litigation Reform Act of 1995. These forward-looking statements are based
upon current expectations and assumptions about our business that are subject to a
variety of risks and uncertainties that could cause actual results to differ materially
from those described in this presentation. You should not rely on forward-looking
statements as a prediction of future events. 
Additional information regarding factors that could cause actual results to differ
materially from those discussed in any forward-looking statements are described in
reports and registration statements we file with the SEC, including our Annual Report
on Form 10-K and subsequent Quarterly Reports on Form 10-Q and Current Reports on
Form 8-K, copies of which are available on the Amedisys internet website 
                             
department at (800) 467-2662. 
We disclaim any obligation to update any forward-looking statements or any changes in
events, conditions or circumstances upon which any forward-looking statement may be
based except as required by law.
http://www.amedisys.com
or by contacting the Amedisys Investor Relations

2011 Investor Meeting
Meeting flow
Now –
11:45 am
Morning Presentations
11:45 –
12:45
Lunch / break
12:45 -
3 pm
Afternoon presentations
3

2011 Investor Meeting
State of the Company
William F. Borne, Chairman and CEO
4

2011 Investor Meeting
Goals
Showcase the way we’ve optimized our operations
Clearly define our growth strategy
Reiterate our commitment to compliance
5

2011 Investor Meeting
6
Today’s presenters
William F. Borne,
Chairman & CEO
Michael Snow,
Chief Operating Officer
Michael Fleming,
MD, FAAFP
Chief Medical Officer
Jeffrey Jeter, JD
Chief Compliance Officer
Dave Monic, VP
Clinical Informatics
Patrick Thompson,
EVP Administration
Chief Information Officer
Leigh Ann Witcher
Templeton,
VP Office Informatics
Kendra Case, VP
Clinical Development

2011 Investor Meeting
Company Overview
“Leading Home Health & Hospice”
7

2011 Investor Meeting
Leading Home Health & Hospice
Traditional Measures –
Home Health
8
Amedisys
Gentiva
LHCG
Almost
Family
Home Health
Revenue
(2010 -
$M)
$1,493
$1,096
$559
$295
States
Serving
45
39
19
11
Total
Locations
489
350+
251
87

2011 Investor Meeting
Leading Home Health & Hospice
Traditional Measures -
Hospice
9
Amedisys
Gentiva
LHCG
Vitas
Hospice
Revenue
(2010 -
$M)
$141
$800
~$40
$925
States
Serving
20
30
9
15
Total
Locations
69
170
33
102

2011 Investor Meeting
Differentiating industry leadership metrics
Management
•
Strong Home Health and Hospice leadership
Commitment to quality
•
National roll-out of Care Transitions
•
Numerous quality pilot programs and “R&D”
•
Focus on reducing acute care hospitalizations
Focus on the care continuum
•
Clinical innovation in advanced chronic care management
•
Collaborative technology
•
Engaging regulators and policy-makers in Washington
Patti Waller, EVP
Home Health Care
Jim Robinson, EVP
Hospice Care

2011 Investor Meeting
11
2011 Overview
•
After tremendous growth,
2010 was a year to reset
–
Decentralize operations
–
Leadership investments
–
In-depth portfolio review
–
Re-focus on costs
–
Next generation IT investments
•
2011 Headwinds
–
~ 5% cut to home health
–
F2F/Therapy Assessments
–
Slower growth
$-
$500
$1,000
$1,500
$2,000
2007
2008
2009
2010
$ Millions
Amedisys
Historical Financials
Revenue
EBITDA

2011 Investor Meeting
Lifestyle / Chronic Disease: Obesity in America
Percent
of
Obese
U.S.
Adults
(BMI
>
30)
12

13
>
$2.5 trillion / year
>
$800
billion
–
$1.2 trillion in waste
>
$6.2 trillion in cuts /
10 years
We are facing a crisis.
2011 Investor Meeting

2011 Investor Meeting
A New Path: National Reform Efforts
Patient-Centered
Medical Home
Value-Based
Purchasing
Independence
at Home
Accountable Care
Organizations
Bundled Payments
Pay-for-Performance
14

Migration from episode
management to continuum
management
Lower-cost setting with industry-
leading technology, processes and
talent that make us efficient
These are our patients
Why is Amedisys
Part of the Answer?
AGING
POPULATION
WASTE 
INEFFICIENCY
LIFESTYLE /
CHRONIC
DISEASE
15
2011 Investor Meeting

Evolution of traditional
home health
16

Current State: Post-Acute Care
Traditional Home Care Episode
Acute
Episode
(HF)
Home Health
Treatment
Home Health
Treatment
Home Health
Treatment
Acute
Episode
(HF)
Patient
discharged from
hospital to home
care
Patient continuing
to improve, home
care is recertified
CHF stable, 
patient
discharged from
home care
New CHF
exacerbation &
hospital
admission
0
3
60
120
200
205
Timeline
Episode
Begins
Again…
17
Traditional
Home Care

Future State
Continuum of Care
Physician
Visit
Continuous Care Management
Home Care Assessment &
Visits
NP
Home
Visit
Office visit triggers physician
to order management and
coordination at home
Possible exacerbation
reported via
telehealth/monitoring
Patient assessment; clinical track
assigned; medication reconciliation;
patient education;
telehealth/monitoring
Immediate clinician visit; physician
notified; plan of care assessed and
modified
Increased Therapy &
Nursing Visits
Chronic disease management --
possibly under
capitation or other risk-based model
18
Timeline

2011 Investor Meeting
The Amedisys strategic roadmap
Patients /
health care
system 
value
Today:  Focus on the basics and
prepare for change
Tomorrow:  Differentiated   
provider of care
management
•Build Infrastructure
•Organic Growth
•Grow Hospice
•Advance Care
Capabilities
•Policy Dialogue
19
•Care management
capability
•Revenue diversity
-
Hospitals
-
Health systems
-
Managed care
•Capitation / Risk Sharing
•Collaborative IT
•Policy engagement

2011 Investor Meeting
Operations update
Mike Snow, Chief Operating Officer
20

2011 Investor Meeting
Rapid growth
In the past two and a half years (2007–
2010),
Amedisys
has grown from:
9,000 employees to 17,000
354 sites to more than 550 today
$700M
in
revenues
to
$1.65B
1
today
21
1
Annualized revenue guidance provided as of the date of our Form
8-K filed with the Securities and Exchange
Commission on August 9, 2010.

2011 Investor Meeting
Agency Locations
22
489 -
Home Health locations
69 -
Hospice locations
Beacon Hospice Care Centers
Amedisys
Hospice
Care
Centers
Amedisys
Home
Health
Care
Centers

2011 Investor Meeting
Balancing centralized resources and
decentralized ownership of markets
23
Engaged talent.
Tools for success.
Grow local markets.
2011 Investor Meeting

Our Long-term Operating Tenets
24
2011 Investor Meeting

2011 Investor Meeting
Focus on Clinical Outcomes
25
Amedisys
vs. Footprint –
Outcomes December 2009
•
Exceeded or met 11 out of 12 outcomes vs. footprint
1
Lower % is better          Source:  Medicare

2011 Investor Meeting
Quality Care Initiatives
26

2011 Investor Meeting
Focus on Clinical Outcomes
27
•
Internal ACH rate –
Trailing 12 Months
Note: Data only includes agencies in the 2009 Baseline dataset
.

2011 Investor Meeting
The Numbers
Current Medicare Readmission Rates
Rehospitalizations
among Patients in the Medicare Fee-for-Service Program. Stephen F. Jencks, M.D., M.P.H.,
Mark V. Williams,
M.D.,
and
Eric
A.
Coleman,
M.D.,
M.P.H.
N
Engl
J
Med
2009;
360:1418-1428April
2,
2009
28

2011 Investor Meeting
Growth -
Organic
29
Tactical growth initiatives
•
Care center action plans
•
Heightened focus on low performers
•
Leading indicators
•
Measure effectiveness
1
Same store episodic-based
admission
growth
is
the
percent
increase
in
our
same
store
episodic-based
admissions
for
the
period
as
a
percent
of
the
same
store
episodic-based
admissions
of the
prior period.
•
New regional leadership
•
Training & development
•
CRM tool / market intel
•
Incentive alignment
3%
6%
-2%
15%
12%
18%
-5%
0%
5%
10%
15%
20%
2009
2010
1Q 2011
Same Store Episodic-Based
Admission Growth
1
Home Health
Hospice

2011 Investor Meeting
Growth -
Organic
30
Strategic growth initiatives

2011 Investor Meeting
Growth -
External
31
Industry Consolidation
–
10,500 home health
provider numbers
–
3,400 hospice provider
numbers
–
12-15% public company
market share
Focus
–
CON markets
–
Geographic expansion
–
Market penetration
–
Hospital JV’s
Continuum of care
Traditional Investments
Complementary Investments
–
Care management capabilities
–
Revenue diversification
–
Disease Management

2011 Investor Meeting
Beacon Acquisition
•
Premier hospice in Northeast
–
23 locations
–
$80 million in revenue
–
Quality provider
–
Strong leadership and operations
32
Beacon Hospice Care Centers
Amedisys
Hospice Care Centers
Amedisys
Home Health Care Centers

2011 Investor Meeting
Efficiency –
Systems Infrastructure
33

Efficiency –
labor
34
•
Cost per visit improvements
-
Pay per visit focus
-
Reduction in overtime
-
Weekly visit metrics
•
Field Overhead
-
Staffing ratios
-
Streamline leadership
-
Closures/Mergers
•
Hospice
-
Reduced pharma
costs
-
Leverage overhead thru growth
1
*Adjusted for holiday pay and inclement weather
$71.00
$71.50
$72.00
$72.50
$73.00
$73.50
$74.00
$74.50
$78.00
$78.50
$79.00
$79.50
$80.00
$80.50
$81.00
$81.50
$82.00
$82.50
$83.00
1Q 10
2Q 10
3Q 10
4Q 10
1Q 11
Home Health Cost per Visit*
Hospice Cost per Day
2011 Investor Meeting

2011 Investor Meeting
The Paradigm Shift
35
Green LA, Fryer GE Jr, Yawn BP, Lanier D, Dovey SM. The ecology of medical care revisited. N Engl J Med. 2001 Jun 28;344(26):2021-5.

2011 Investor Meeting
We’re Ready
36

2011 Investor Meeting
Quality = growth
Michael Fleming, MD, FAAFP -
Chief Medical Officer
Kendra Case, VP Clinical Development
37

2011 Investor Meeting
Amedisys Strategic Advisory Board
38
Dr. Peter Boling
Virginia Commonwealth
University
Dr. Allen Dobson
Carolinas Healthcare System/
Cabarrus Family Medicine
Dr. Steven Landers
Cleveland Clinic
Dr. Bruce Leff
Johns Hopkins University School
of Medicine
Dr. Mike Magee
Positive Medicine, Inc.
Dr. Frank Opelka
Louisiana State University
Health Sciences Center

2011 Investor Meeting
Physician Engagement: Power of the Pen
39

2011 Investor Meeting
Defining Quality in Healthcare
Institute of Medicine’s Characteristics for Quality Care
40

2011 Investor Meeting
“It is not the strongest of the species that
survives, nor the most intelligent, but
the one most responsive to change.”
-
Charles Darwin
41

2011 Investor Meeting
We’re Evolving
42

2011 Investor Meeting
Amedisys
clinical resources are second to none.
43
Provides guidance,
education, and clinical
infrastructure to the
care centers to comply
with  federal as well as
state regulatory bodies

2011 Investor Meeting
Amedisys
clinical resources are second to none.
44
Provides support to
care centers to ensure
they are in compliance
with license renewals,
personnel changes,
CON reporting
requirements etc

2011 Investor Meeting
•
Create and Manage
Condition-Specific
Programs
•
Create and Manage
Chronic Disease
Programs
•
Corporate clinical
support for other
general programs
•
Research &
Development
Amedisys
clinical resources are second to none.
45

2011 Investor Meeting
Evidence-based Programs
Partners in Wound
Care®
Wound Care
Rehab Therapy  @
Home
Rehabilitation
Empowered
for Life
Psychiatric
Surgical Recovery   @
Home
Post Surgery
COPD @ Home
Chronic Obstructive
Pulmonary Disease
Diabetes @ Home
Diabetes
Heart @ Home
Cardiac Disease
Stroke Recovery
@ Home
Stroke
Chronic Kidney
Disease @ Home
Kidney Disease
Pain Management        
@ Home
Chronic Pain
Balanced for Life
Fall Prevention
Enables our clinical staff to provide the highest level of
care consistently nationwide while controlling costs
through a demonstrated plan of care

Care Transitions Program
47
•
Coordinate transition to
home care
•
Initiate patient health
history and patient health
•
Promote follow-up
physician visit
•
Initiate medication
•
Patient
education
&
coaching
•
Medication
management
•
Patient
self-management
of chronic diseases (Bridge
to Healthy Living)
•
Focus
on
Physician
follow-
up and engagement
record
reconciliation
2011 Investor Meeting

www.cardiocom.com
Telemonitoring:
Helping Amedisys
effectively and
efficiently monitor
complex patients in
their home
Remote Patient Monitoring
48

2011 Investor Meeting
Advanced Chronic Care Management
49

Spotlight On
Palliative Care @ Home
Terminal
Phase of
Illness
Diagnosis
World Health Organization (2002)
50

Home-based Palliative Care
51

Innovation of Health Care at Home
52
Care Transitions pilot for congestive heart failure population
HCA Richmond Care Preferred Provider –
CHF patients
Palliative Care / End-of-Life Care
2011 Investor Meeting

53
Questions & Answers
Morning Session
2011 Investor Meeting

2011 Investor Meeting
Home health day-to-day operations overview
•
Provide investors better clarity on home health operations and billing
•
Describe our IT investment and the efficiencies it drives
•
Compliance wraps it up
Agenda
•
IT systems that support daily operations
•
Overview of process from referral to final billing
•
Point-of-Care demonstration
•
Clinical management
•
Mercury Doc
•
Compliance
54
Afternoon Overview

2011 Investor Meeting
Best-in-class technology
Patrick Thompson, EVP Administration and CIO
55

Quality
–
Point-of-care
–
Clinicians at patient’s home
–
Clinical Management oversight
–
Circle of Care tools for patients and
care teams
–
Consistent & enhanced clinician
training and delivery of @Home
services
Efficiency
–
Mobile workforce
–
Care Center efficiencies
–
Back-office  automation
–
Collaboration & Communication
–
Agility & Speed of Business
–
Continuum Care solutions
Growth
–
Market intelligence
–
Focused Targets
–
Enhance communication with
referral sources
–
Scalability
–
Acquisition optimization
The Amedisys
IT mission:
•
Support the company’s core tenets
•
Provide the right info, at the right time, anywhere
2011 Investor Meeting

57
Clinical  & Office Informatics
Amedisys
Continuum Care Enterprise Information System
Skill match scheduling with patient needs
Multi-Care Center scheduling to optimize mobile
workforce
Productivity scheduling to optimize workforce
2011 Investor Meeting

58
Clinical  & Office Informatics
Amedisys
Continuum Care Enterprise Information System
Patient care at bedside
Evidence based rules
Clinical tracks and modules
14,000 mobile clinicians
Smart edits
Re-Hospitalization alerts
2011 Investor Meeting

59
Clinical  & Office Informatics
Amedisys
Continuum Care Enterprise Information System
10,000,000 visits for 400,000 patients annually
Clinical management dashboards
Quality Care alerts
Re-Hospitalization alerts
2011 Investor Meeting

60
Clinical  & Office Informatics
Amedisys
Continuum Care Enterprise Information System
Greater than 99 percent Medicare collection rate
Driving down DSO rate
Automated billing
2011 Investor Meeting

2011 Investor Meeting
61
Amedisys
Continuum Care Enterprise Information System
Reduce inventory on shelf
Just in time delivery to patient home
Order from care plan
Clinical  & Office Informatics

2011 Investor Meeting
62
Millions of patients trends and care analysis
Role based dashboards for all key care center roles
Re-Hospitalization alerts
Productivity alerts
Enterprise Business & Client Systems Platform
Clinical  & Office Informatics
Amedisys
Continuum Care Enterprise Information System

2011 Investor Meeting
63
Amedisys
Continuum Care Enterprise Information System
Referral capture
Integration with CIS
Care Transition Solution
Productivity alerts
Clinical  & Office Informatics
Enterprise Business & Client Systems Platform

2011 Investor Meeting
64
Amedisys
Continuum Care Enterprise Information System
Circle of Care
Physician portal
Patient/family portal
Care Team portal
Enterprise Business & Client Systems Platform
Clinical  & Office Informatics

2011 Investor Meeting
65
Amedisys
Continuum Care Enterprise Information System
Financials
HR
Payroll
Supply Chain
Clinical  & Office Informatics
Enterprise Business & Client Systems Platform

2011 Investor Meeting
66
Amedisys
Continuum Care Enterprise Information System
Over 8,000 physicians
27% admissions
Collaborative Care
Medical reconciliation
Re-Hospitalization alerts
Clinical  & Office Informatics
Enterprise Business & Client Systems Platform

2011 Investor Meeting
67
Clinical  & Office Informatics
Amedisys
Continuum Care Enterprise Information System
Enterprise Business & Client Systems Platform
@ Home
Hospice
Hospitals

2011 Investor Meeting
Medicare Billing/
Reimbursement Overview
Kendra Case, VP Clinical Development
68

2011 Investor Meeting
Medicare Billing/Reimbursement Overview
69
PROCESS
Referral sources
•
Hospitals
•
Physicians
•
Other facilities
1
Referral
2
Initial
Visit
3
Plan of
Care
Developed
4
Locked
OASIS
5
The
RAP
6
7
Plan of
Care
Implemented
Final Bill
&
Payment
F2F initiated
•
Prior to discharge
•
Upon admission

2011 Investor Meeting
Medicare Billing/Reimbursement Overview
70
PROCESS
1.5 –
2 hour clinician assessment
•
OASIS
•
POC technology
•
Data checks
1
Referral
2
Initial
Visit
3
Plan of
Care
Developed
4
Locked
OASIS
5
The
RAP
6
7
Plan of
Care
Implemented
Final Bill
&
Payment

2011 Investor Meeting
Medicare Billing/Reimbursement Overview
71
PROCESS
Development
•
Created by RN or
PT
•
Clinical Tracks
•
Certification
1
Referral
2
Initial
Visit
3
Plan of
Care
Developed
4
Locked
OASIS
5
The
RAP
6
7
Plan of
Care
Implemented
Final Bill
&
Payment

2011 Investor Meeting
Medicare Billing/Reimbursement Overview
72
PROCESS
1
Referral
2
Initial
Visit
3
Plan of
Care
Developed
4
Locked
OASIS
5
The
RAP
6
7
Plan of
Care
Implemented
Final Bill
&
Payment

2011 Investor Meeting
Medicare Billing/Reimbursement Overview
73
PROCESS
Coding accuracy
•
Manually Calculated Audits
•
FI Audits
-
ADRs or Probe Edits
1
Referral
2
Initial
Visit
3
Plan of
Care
Developed
4
Locked
OASIS
5
The
RAP
6
7
Plan of
Care
Implemented
Final Bill
&
Payment

2011 Investor Meeting
Medicare Billing/Reimbursement Overview
74
PROCESS
•
The RAP is sent to the FI
•
The FI sends the RAP through its own scrubber
1
Referral
2
Initial
Visit
3
Plan of
Care
Developed
4
Locked
OASIS
5
The
RAP
6
7
Plan of
Care
Implemented
Final Bill
&
Payment

2011 Investor Meeting
Medicare Billing/Reimbursement Overview
75
PROCESS
•
Plan of Care Implemented
•
Changes require MD order
1
Referral
2
Initial
Visit
3
Plan of
Care
Developed
4
Locked
OASIS
5
The
RAP
6
7
Plan of
Care
Implemented
Final Bill
&
Payment

2011 Investor Meeting
Medicare Billing/Reimbursement Overview
76
PROCESS
•
Final bill sent to FI
•
FI Scrubber
1
Referral
2
Initial
Visit
3
Plan of
Care
Developed
4
Locked
OASIS
5
The
RAP
6
7
Final Bill
&
Payment
Plan of
Care
Implemented
>
F2F must be complete

2011 Investor Meeting
Medicare Billing/Reimbursement Overview
77
PROCESS SUMMARY
•
Care Team Driven
(physician/clinician)
•
The patient condition, the OASIS, and
the Plan-of-Care must match
•
The patient must agree to the plan

2011 Investor Meeting
Best-in-class processes + systems
Leigh Ann Witcher Templeton, VP Office Informatics
Kendra Case, VP Clinical Development
78

2011 Investor Meeting
79
Leigh Ann Witcher Templeton, VP Office Informatics
**LIVE DEMO IN PROGRESS**

2011 Investor Meeting
80
Point of Care –
Clinical Managers
Kendra Case, VP Clinical Development

2011 Investor Meeting
MercuryDoc
Dave Monic, VP Clinical Informatics 
81

2011 Investor Meeting
Introduction
82

2011 Investor Meeting
Mercury Doc:
Stats
Over 8,000 physicians currently enrolled
Over 50,000 home health orders processed
each month
1/3 of Amedisys patient volume is processed
through MercuryDoc

2011 Investor Meeting
Mercury Doc Physician Advantages
Less paperwork
Greater efficiency
=
MORE TIME FOR PATIENTS!

2011 Investor Meeting
Mercury Doc Physician
Advantages
Online access to home care patients’:
•
Demographic
info
•
Medication,
allergy &
pharmacy
info
•
Graphed
trends
& vitals
•
Wound
care info
•
Refer patients
to Amedisys
Complementary to the physician

2011 Investor Meeting
Future of Mercury Doc
Physician-driven
AMDAG:
•
Amedisys Medical Director
Advisory Group
•
Established in July of 2005 as
the Quality and Technology
Board
•
Direct Feedback from
Physicians on
Emerging Technologies
•
Aid in Design and Quality
Assurance
Survey:
•
Survey done semi-annually
•
Development is driven by
physicians, therefore,
participation is vital.
•
Prompted to participate when
logging into product.
•
Survey takes less than ten (10)
minutes to complete.
–
Seven (7) multiple choice
questions.
–
Three (3) free text questions.

2011 Investor Meeting
Mercury Doc: Future Enhancements
•
Amedisys is constantly gathering physician input on how to
enhance MercuryDoc to remain in step with ever changing
physician work flow needs.
•
We are currently working on 2010 AMDAG recommendations
regarding managing/reducing re-hospitalizations
What are doctors saying about…

2011 Investor Meeting
88
Questions & Answers
Afternoon Session

2011 Investor Meeting
Compliance @ Amedisys
A Comparison of Amedisys Compliance
to OIG Best Practices
Jeffrey Jeter, Chief Compliance Officer 
89

2011 Investor Meeting
Federal Perspectives on
Health Care Fraud Prevention
OIG Health Care Fraud
Prevention & Enforcement 
Action Team (HEAT)
90
February-April, 2011: OIG HEAT Provider Compliance Training
What are the
best practices
reflecting a
strong culture of
compliance?

2011 Investor Meeting
Seven Fundamental Elements of Compliance
91

2011 Investor Meeting
Compliance Fundamental #1:
Written Policies, Procedures, Standards
92

2011 Investor Meeting
Compliance
Fundamental
#1:
Written Policies, Procedures, Standards
93
•
Adopted in 1999
•
Consistent with OIG Model Compliance
Plan Guidance for both Home Health and
Hospice.
•
Revisions made in 1999, 2000, 2002,
2003, 2006, 2008, 2009, 2010, 2011.
•
Disseminated company-wide via Amedisys
Intranet (Amedisys @ Work).
Amedisys
Practice

2011 Investor Meeting
Compliance
Fundamental
#2:
Access to Compliance Professionals
94
OIG Best
Practice

2011 Investor Meeting
•
Designation of Chief Compliance Officer
•
Designation of Compliance Committee
•
Access to Board of Directors, Management
•
Professional Staff
OIG Best
Practice
Compliance
Fundamental
#2:
Access to Compliance Professionals
95

2011 Investor Meeting
-
Jeffrey Jeter, former health care fraud prosecutor
-
CEO,
COO,
CFO,
CDO,
CMO,
CIO,
CCO,
SVP-Internal
Audit, SVP-Clinical Informatics, VP-Compliance  
-
Quarterly reports to Board of Directors
-
Executive Session with independent directors
-
Direct access to chair of Audit Committee (SOX)
-
Staff of 21 dedicated employees.
-
Includes 11 clinical auditors, 2 attorneys, 1 CPA/CIA
•
Designation of Chief Compliance Officer
•
Designation of Compliance Committee
•
Access to Board of Directors, Management
•
Professional Staff
Amedisys
Practice
Compliance
Fundamental
#2:
Access to Compliance Professionals
96

2011 Investor Meeting
Compliance
Fundamental
#3:
Effective Training & Education
97
OIG Best
Practice

2011 Investor Meeting
Compliance
Fundamental
#3:
Effective Training & Education
98
•
Mandatory general compliance training upon hire
•
Mandatory refresher training annually
•
Mandatory HIPAA training annually
•
Targeted training for billing staff
•
Targeted training for business development staff
Amedisys
Practice

2011 Investor Meeting
Compliance
Fundamental
#4:
Effective Communication
99
OIG Best
Practice

2011 Investor Meeting
Compliance
Fundamental
#4:
Effective Communication
100
•
Toll-Free Compliance Hotline
•
Toll-Free HIPAA Hotline
•
Exit Interviews
•
Monthly Polling
•
Confidentiality / Non-retaliation policy
•
Compliance Educational Bulletins
Amedisys
Practice

2011 Investor Meeting
Compliance
Fundamental
#5:
Internal Monitoring
101
OIG Best
Practice

2011 Investor Meeting
•
Clinical Audits  (Services, Coding, and Care)
-
Complaint Audits
-
Compliance Scorecard Audits
-
Annual Work Plan Audits
-
Due Diligence Audits
•
Medical Director Contract & Invoice Review
•
Expense Report Monitoring
•
Training & Marketing Material Reviews
Amedisys
Practice
Compliance
Fundamental
#5:
Internal Monitoring
102

2011 Investor Meeting
Compliance
Fundamental
#5:
Internal Monitoring
103
•
Clinical Audits  (all-inclusive)
•
Medical Director Contract Review
•
Medical Director Payment Review
•
Expense Report Monitoring
•
Training & Marketing Material Reviews
Amedisys
Practice

2011 Investor Meeting
Compliance
Fundamental
#5:
Internal Monitoring
104
OIG Best
Practice

2011 Investor Meeting
Compliance
Fundamental
#5:
Internal Monitoring
105
•Compliance Risk Scorecard
-
Home Health (since 2008)
-
Hospice (currently under development)
•2010 —
282 full scale audits and 750 limited  scope
chart reviews.
•2010—5 company-wide special project audits   (tied
to OIG Annual Workplan)
•Special compliance audits conducted on all
acquisition targets.
Amedisys
Practice

2011 Investor Meeting
106
Compliance
Fundamental
#5:
Proactive Internal Monitoring
Consolidated
Compliance Risk
100%
Roll-Up
Company
Average
Up to
2
Standard
Deviations
2
Standard
Deviations
Operational
Risks
Company
Average
Up to
2
Standard
Deviations
2
Standard
Deviations
Clinical Risks
Company
Average
Up to
2
Standard
Deviations
2
Standard
Deviations
Revenue Risks
Company
Average
Up to
2
Standard
Deviations
2
Standard
Deviations
Complaint Risks
Company
Average
Up to
2
Standard
Deviations
2
Standard
Deviations
Regulatory Risks
Company
Average
Up to
2
Standard
Deviations
2
Standard
Deviations
Environmental Risks
Company
Average
Up to
2
Standard
Deviations
2
Standard
Deviations

2011 Investor Meeting
HOSPICE COMPLIANCE SCORECARD
(Under Development in 2011)
Compliance
Fundamental
#5:
Proactive Internal Monitoring

2011 Investor Meeting
Compliance
Fundamentals
#s
6
&
7:
Enforcement of Standards, Prompt Response
108
OIG Best
Practice

2011 Investor Meeting
Compliance Fundamentals #s 6 & 7:
Enforcement of Standards, Prompt Response
109
Amedisys
Practice
•Zero Tolerance Policy
•Expanded Zero Tolerance
•Disciplinary action up to and including
termination.
•Employees who engage in fraudulent
conduct are reported to professional
licensing boards.
•Corrective action plans and training are           
required remediation with any audit.  

2011 Investor Meeting
Amedisys
Compliance
vs.
OIG
Best
Practices
110
These best practices reflect a culture of compliance, which means
doing
the
right
thing
naturally.
Lewis
Morris,
Chief
Counsel
to
the
OIG,
04-12-2011

2011 Investor Meeting
111
Questions & Answers
Compliance

2011 Investor Meeting
112
Closing Remarks
William F. Borne, Chairman and CEO
Mike Snow, Chief Operating Officer

Evolution of traditional
home health
113

Thank you
2011 Investor Meeting -
NYC  
April 2011